What is THC Farmaceuticals, Inc.'s annual revenue?

THC Farmaceuticals, Inc. (CBDG) reported annual revenue of $0 in its most recent fiscal year.

What is THC Farmaceuticals, Inc.'s net profit?

THC Farmaceuticals, Inc. (CBDG) reported net profit of $0 in its most recent fiscal year.

What is CBDG EV/EBITDA?

THC Farmaceuticals, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -39.22. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

OTC · Financial Statements

THC Farmaceuticals, Inc. (CBDG) Financial Statements

$0.03 OTC: CBDG Market Cap $505872

THC Farmaceuticals, Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric	2020	2021	2022	2023	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$0	$0	$0	$0	$0
Net Profit	$0	$0	$0	$0	$0
EPS	$0.00	$0.00	$0.02	$0.00	$0.00
Op Margin	-431.7%	-797.2%	-84.9%	—	—

Balance Sheet (USD)

Metric	2020	2021	2022	2023	2025
Total Assets	$2.0M	$3.0M	$3.0M	$3.0M	$3.0M
Total Liabilities	$1.0M	$1.0M	$0	$0	$0
Cash	$0	$0	$0	$0	$0
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2020	2021	2022	2023	2025
Operating Cash Flow	$0	$0	$0	$1.0M	—
Investing Cash Flow	$0	$0	$0	$-1.0M	—
Financing Cash Flow	$0	$0	$0	$0	—
Net Cash Flow	$0	$0	$0	$0	—
Free Cash Flow	$0	$0	$0	$1.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.47
EV / EBITDA	-39.22
FCF Yield	125.63%
Quick Ratio	0.00
Interest Coverage	—
Return 1Y	-43.06%
Return 3Y	6875.00%
Return 5Y	—

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

CBDG Overview CBDG Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.